Sign in or register to see full information and data.

Studies / CAVD 472


Study information

Grant Affiliation:Hope: Antibody-Mucus Interactions
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2014-12-03
Study Made Public:2016-09-22


Neutralization assay using the MUC5AC at constant concentration of (0.5mg/ml) and serial dilution of HIV-1 antibody panel.


CAVD 472 (MUC5AC) is an immunogenicity study to identify which antibodies respond to the presence of MUC5a/c, an oligomeric gel forming human mucin subtype.


No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.